Peripheral_JJ
T_NN
lymphocytes_NNS
from_IN
women_NNS
with_IN
breast_NN
cancer_NN
exhibit_VBP
abnormal_JJ
protein_NN
expression_NN
of_IN
several_JJ
signaling_NN
molecules_NNS
._.

We_PRP
examined_VBD
signaling_NN
molecules_NNS
of_IN
peripheral_JJ
blood_NN
T_NN
lymphocytes_NNS
obtained_VBN
from_IN
women_NNS
with_IN
breast_NN
cancer_NN
._.

In_IN
6_CD
of_IN
14_CD
patients_NNS
,_,
T_NN
lymphocytes_NNS
displayed_VBD
an_DT
impaired_JJ
ability_NN
to_TO
translocate_VB
NFeB_NN
p65_NN
-LRB-_-LRB-
Rel-A_NN
-RRB-_-RRB-
following_VBG
activation_NN
by_IN
anti-CD3_NN
and_CC
IL-2_NN
._.

This_DT
observation_NN
was_VBD
made_VBN
despite_IN
normal_JJ
cytoplasmic_JJ
levels_NNS
of_IN
the_DT
Rel-A_NN
protein_NN
._.

We_PRP
also_RB
detected_VBD
abnormally_RB
low_JJ
levels_NNS
of_IN
the_DT
signaling_VBG
molecules_NNS
T-cell_NN
receptor_NN
-LRB-_-LRB-
TCR_NN
-RRB-_-RRB-
-_CC
zeta_NN
,_,
ZAP-70_NN
and_CC
p56lck_NN
in_IN
4_CD
of_IN
14_CD
breast_NN
cancer_NN
patients_NNS
,_,
i.e._FW
,_,
defects_NNS
in_IN
T-cell_NN
signaling_VBG
molecules_NNS
._.

T_NN
lymphocytes_NNS
from_IN
6_CD
of_IN
the_DT
14_CD
patients_NNS
also_RB
exhibited_VBD
an_DT
increased_VBN
expression_NN
of_IN
the_DT
dual_JJ
specificity_NN
phosphatase_NN
,_,
map_NN
kinase_NN
phosphatase-1_NN
-LRB-_-LRB-
MKP-1_NN
-RRB-_-RRB-
._.

MKP-1_NN
inactivates_VBZ
MAP_NN
kinase_NN
and_CC
therefore_RB
may_MD
interfere_VB
with_IN
the_DT
activation_NN
of_IN
c-jun_NN
and_CC
c-fos_NN
._.

Abnormalities_NNS
of_IN
I_CD
or_CC
more_JJR
signaling_NN
molecules_NNS
were_VBD
found_VBN
in_IN
9_CD
of_IN
14_CD
patients_NNS
;_:
however_RB
,_,
only_RB
3_CD
patients_NNS
had_VBD
T_NN
cells_NNS
that_WDT
exhibited_VBD
all_DT
5_CD
defects_NNS
._.

Our_PRP$
data_NNS
have_VBP
implications_NNS
for_IN
the_DT
detection_NN
of_IN
potentially_RB
dysfunctional_JJ
T_NN
cells_NNS
in_IN
patients_NNS
with_IN
cancer_NN
._.

For_IN
example_NN
,_,
the_DT
analysis_NN
of_IN
only_RB
1_CD
signaling_VBG
molecule_NN
may_MD
allow_VB
patients_NNS
with_IN
significant_JJ
defects_NNS
in_IN
T-cell_NN
signaling_NN
to_TO
go_VB
unnoticed_JJ
._.

Finally_RB
,_,
despite_IN
impaired_JJ
Rel-A_NN
translocation_NN
,_,
T_NN
cells_NNS
were_VBD
capable_JJ
of_IN
transcribing_VBG
IL-2_NN
._.

Impairments_NNS
in_IN
the_DT
translocation_NN
of_IN
Rel-B_NN
and_CC
c-Rel_NN
further_RB
suggest_VBP
that_IN
the_DT
NFKB_NN
family_NN
members_NNS
Rel-A_NN
,_,
Rel-B_NN
and_CC
c-Rel_NN
are_VBP
not_RB
required_VBN
for_IN
the_DT
transcription_NN
of_IN
IL-2_NN
in_IN
the_DT
peripheral_JJ
T_NN
lymphocytes_NNS
of_IN
patients_NNS
with_IN
breast_NN
cancer_NN
._.

